{
  "id": "cluster_2_doc3",
  "content": "Claims analysis shows 47% increase in prior auth appeals for biologic therapies in Southern California region (Q1 2024). Notable concentration around Coastal Regional Hospital referrals. Common denial reasons include incomplete antibody panels and missing treatment algorithms from prescribing providers.",
  "metadata": {
    "format": "audit_report"
  }
}